✦ LIBER ✦

Spatial distribution of human cell survival in a neutron beam designed for therapy

✍ Scribed by Paul Todd; Carter B. Schroy; F. H. Attix; Richard B. Theus

Publisher: John Wiley and Sons
Year: 1974
Tongue: English
Weight: 502 KB
Volume: 34
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(197407)34:1<33::aid-cncr2820340106>3.0.co;2-j

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Spatial distribution of human cell survi

Spatial distribution of human cell survival and oxygen effect in a therapeutic helium ion beam

✍ Paul Todd; Bambino I. Martins; John T. Lyman; J.-H. Kim; Carter B. Schroy 📂 Article 📅 1974 🏛 John Wiley and Sons 🌐 English ⚖ 380 KB

Anti-CD3-based bispecific antibody desig

Anti-CD3-based bispecific antibody designed for therapy of human B-cell malignancy can induce T-cell activation by antigen-dependent and antigen-independent mechanisms

✍ Brian K. Link; Sheri A. Kostelny; Michael S. Cole; William P. Fusselman; J. Yun 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 French ⚖ 107 KB 👁 2 views

## Anti -CD3 ؋ anti-B-cell antigen bispecific monoclonal antibodies (bsAbs) can redirect T-cell-mediated lysis toward malignant B cells. Clinical trials with CD3-based bsAbs have shown toxicity in patients which is likely related to nonspecific T-cell activation and targeting. Our current studies

A simple catheter-vessel model for MR as

A simple catheter-vessel model for MR assessment of drug distribution in arteries and optimization of catheter design for intraarterial infusion therapy

✍ Takeshi Yoshikawa; Koji Uchida; Yoshiharu Ohno; Shozo Hirota; Tomonori Nakamura; 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 564 KB

## Abstract ## Purpose To investigate the efficacy of a new catheter‐vessel model for MRI to evaluate drug distribution and to optimize catheter design for intraarterial infusion therapy ## Materials and Methods The model consisted of a hepatic artery simulant tube through which blood simulant w

A Comparison of Survival and Disease-Spe

A Comparison of Survival and Disease-Specific Survival in Surgically Resected, Lymph Node-Positive Bronchioloalveolar Carcinoma Versus Nonsmall Cell Lung Cancer: Implications for Adjuvant Therapy

✍ David H. Garfield; Wilbur A. Franklin 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 62 KB 👁 1 views

T he recent article by Varlotto et al 1 raises issues that are prob- lematic in the recent and current bronchioloalveolar (BAC) literature. The third edition of the 1999 World Health Organization (WHO) consensus classification redefined BAC as an in situ tumor with a pure BAC growth pattern and with

A comparison of survival and disease-spe

A comparison of survival and disease-specific survival in surgically resected, lymph node-positive bronchioloalveolar carcinoma versus nonsmall cell lung cancer : Implications for adjuvant therapy

✍ John M. Varlotto; John C. Flickinger; Abram Recht; Margaret C. Nikolov; Malcolm 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 151 KB 👁 1 views

## Abstract ## BACKGROUND The objective of this study was to assess whether disease‐specific survival (DSS) and overall survival (OS) differed among patients who had N1 and N2 bronchioloalveolar carcinoma (BAC) compared with patients who had non‐BAC nonsmall cell lung cancer (NSCLC). ## METHODS

Optimization of in vitro expansion of hu

Optimization of in vitro expansion of human multipotent mesenchymal stromal cells for cell-therapy approaches: Further insights in the search for a fetal calf serum substitute

✍ M.E. Bernardo; M.A. Avanzini; C. Perotti; A.M. Cometa; A. Moretta; E. Lenta; C. 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 443 KB

## Abstract There is great interest in mesenchymal stromal cells (MSCs) for cell‐therapy and tissue engineering approaches. MSCs are currently expanded in vitro in the presence of fetal calf serum (FCS); however, FCS raises concerns when used in clinical grade preparations. The aim of this study wa